Skip to main content
×

Webinar: ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on low dose CT screening for lung cancer

Download Event to Calendar

18:00–19:00 CET
Panel Discussion
Chairs/Speakers: Prof. David Baldwin (Nottingham, United Kingdom), Dr Emma O'Dowd (Nottingham, United Kingdom)

Please Click Here for further information and registration

This webinar will see an expert panel discuss the joint ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer.

ERS in close collaboration with ESTS/ESTI, ESTS, ESTRO and EFOMP has recently published 2 Taskforce reports on incidental findings and high-quality standards in LDCT lung cancer programs. Both first authors will present and interactively discuss the key topics of these two European multi-society-driven Taskforce reports. Broad pan-European implementation of these valuable Taskforce reports will help to better tailor LDCT lung cancer screening programs on the national level as well as to increase their efficacy and reduce their potential harms.